Search

Displaying results 4201 - 4210 of 5449 in total
  1. Drug

    IO-202

    go.drugbank.com/drugs/DB17548
    Investigational

    [A257276] It is being investigated in cancers.

  2. Drug

    Hemoglobin glutamer-250 (bovine)

    go.drugbank.com/drugs/DB19235
    Investigational

    Hemoglobin glutamer-250 (bovine) is under investigation in clinical trial NCT00300040 (Safety/feasibility Study of HBOC-201 in Amputation At/below Knee From Critical Lower Limb Ischemia).

  3. Drug

    Peldesine

    go.drugbank.com/drugs/DB02568
    Investigational

    Peldesine is a potent inhibitor of human CCRF-CEM T-cell proliferation. It has undergone phase I trials for the treatment of Human Immunodeficiency Virus (HIV) infections.

  4. Drug

    Amperozide

    go.drugbank.com/drugs/DB08927
    Experimental

    It inhibits dopamine release and alters the firing of dopaminergic neurons. … Alternatively, amperozide's main use lies in veterinary medicine, where it is typically employed to minimize aggression and stress in intensively farmed pigs.

  5. Drug

    Bardoxolone methyl

    go.drugbank.com/drugs/DB05983
    Investigational

  6. Drug

    Cetyl ethylhexanoate

    go.drugbank.com/drugs/DB11349
    Investigational

    It is present in cosmetic products as a skin conditioning agent and emollient.

  7. Drug

    Macadamia seed oil glycereth-8 esters

    go.drugbank.com/drugs/DB14318
    Investigational

    It is not an approved drug.

  8. Drug

    Camrelizumab

    go.drugbank.com/drugs/DB14776
    Investigational

    Camrelizumab is under investigation in clinical trial NCT03417895 (SHR-1210 Combined With Apatinib in Treatment of ED-SCLC After Failure of First Line Standard Therapy).

  9. Drug

    ALM201

    go.drugbank.com/drugs/DB17206
    Investigational

    It is being investigated in the treatment of various cancers.[A254556]

  10. Drug

    Acrizanib

    go.drugbank.com/drugs/DB16081
    Investigational

    Acrizanib is under investigation in clinical trial NCT02355028 (LHA510 Proof-of-concept Study as a Maintenance Therapy for Patients With Wet Age-related Macular Degeneration).